Our team of experts in Patient Centered Solutions (PCS) are specialists in Patient Experience Data (PED). Our recently published book – Using Patient Experience Data to Evaluate Medical Interventions – provides a robust overview of how PED can be generated during intervention development, and how it can be utilized to inform decision-making at the regulatory, payer, healthcare professional and patient levels.
In several chapters of the book, we outline the approaches to generating reliable, valid, meaningful and interpretable PED from qualitative and quantitative exploration. These approaches are, in most cases, tried and tested across drug development programs from various institutions and intervention developers/sponsors. However, there are some populations in which the collection of PED is a bit more difficult.
In chapter 7, we dive deeper on the collection of PED from people with symptoms that make reporting experiences difficult – including pediatrics, CNS, cancer, and rare disease patients.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Capture the patient experience across the full trial process, from strategy to dissemination of results.
.svg){kind=icon}
